Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/206823
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

The quinazolinone allosteric inhibitor of PBP 2a synergizes with piperacillin and tazobactam against methicillin-resistant staphylococcus aureus

AutorJanardhanan, J.; Bouley, R.; Martínez-Caballero, Siseth ; Peng, Z.; Batuecas-Mordillo, Mayte CSIC; Meisel, J.E.; Ding, D.; Schroeder, V.A.; Wolter, W.R.; Mahasenan, Kiran V.; Hermoso, Juan A. CSIC ORCID; Mobashery, S.; Chang, M.
Palabras claveMRS
Aallosterism
Piperacillin
Quinazolinone
Synergy
Tazobactam
Fecha de publicación25-abr-2019
EditorAmerican Society for Microbiology
CitaciónAntimicrobial Agents and Chemotherapy 63:e02637-18 (2019)
ResumenThe quinazolinones are a new class of antibacterials with in vivo efficacy against methicillin-resistant Staphylococcus aureus (MRSA). The quinazolinones target cell wall biosynthesis and have a unique mechanism of action by binding to the allosteric site of penicillin-binding protein 2a (PBP 2a). We investigated the potential for synergism of a lead quinazolinone with several antibiotics of different classes using checkerboard and time-kill assays. The quinazolinone synergized with -lactam antibiotics. The combination of the quinazolinone with commercial piperacillin-tazobactam showed bactericidal synergy at sub-MICs of all three drugs. We demonstrated the efficacy of the triple-drug combination in a mouse MRSA neutropenic thigh infection model. The proposed mechanism for the synergistic activity in MRSA involves inhibition of the -lactamase by tazobactam, which protects piperacillin from hydrolysis, which can then inhibit its target, PBP 2. Furthermore, the quinazolinone binds to the allosteric site of PBP 2a, triggering the allosteric response. This leads to the opening of the active site, which, in turn, binds another molecule of piperacillin. In other words, PBP 2a, which is not normally inhibited by piperacillin, becomes vulnerable to inhibition in the presence of the quinazolinone. The collective effect is the impairment of cell wall biosynthesis, with bactericidal consequence. Two crystal structures for complexes of the antibiotics with PBP 2a provide support for the proposed mechanism of action.
Descripción12 pags., 7 figs., 1 tab.
Versión del editorhttp://dx.doi.org/10.1128/AAC.02637-18
URIhttp://hdl.handle.net/10261/206823
DOI10.1128/AAC.02637-18
Identificadoresdoi: 10.1128/AAC.02637-18
issn: 1098-6596
Aparece en las colecciones: (IQF) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
The quinazolinone allosteri.pdf1,74 MBAdobe PDFVista previa
Visualizar/Abrir
Quinazolinone synergy SI.pdf1,32 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

21
checked on 12-mar-2024

SCOPUSTM   
Citations

37
checked on 12-mar-2024

WEB OF SCIENCETM
Citations

34
checked on 27-feb-2024

Page view(s)

156
checked on 18-mar-2024

Download(s)

339
checked on 18-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.